• 1
    Verbeke L, Farre R, Trebicka J, Komuta M, Roskams T, Klein S, et al. Obeticholic acid, a farnesoid-X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats. Hepatology 2013 Nov 20. doi: 10.1002/hep.26939.
  • 2
    Gracia-Sancho J, Hernández-Gea V, Garcia-Pagán JC. Obeticholic acid, a new light in the shadows treating portal hypertension? Hepatology 2014 Jan 22. doi: 10.1002/hep.27027.
  • 3
    Intercept Pharmaceuticals. Investigational brochure: obeticholic acid. 2012. New York: Intercept Pharmaceuticals, Inc.
  • 4
    Shapiro D, March B, Eliot L, DuBois R, Pruzanski M. First human experience with a synthetic farnesoid X receptor (FXR) agonist—INT-747 (6-ethylchenodeoxycholic acid). Hepatology 2009;50(Suppl S4):198 [Abstract: 992].
  • 5
    Liu LH, Guo Z, Feng M, Wu ZZ, He ZM, Xiong Y. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells. Cell Physiol Biochem 2012;30:14131422.
  • 6
    Weiss SL, Yu M, Jennings L, Haymond S, Zhang G, Wainwright MS. Pilot study of the association of the DDAH2 −449G polymorphism with asymmetric dimethylarginine and hemodynamic shock in pediatric sepsis. PLoS One 2012;7:e33355.
  • 7
    Yang YY, Lee TY, Huang YT, Chan CC, Yeh YC, Lee FY, et al. Asymmetric dimethylarginine (ADMA) determines the improvement of hepatic endothelial dysfunction by vitamin E in cirrhotic rats. Liver Int 2012;32:4857.
  • 8
    Feng M, He ZM, Zhu YX, Liu LH, Lu CW, Xiong Y. Improvement of endothelial dysfunction in atherosclerotic rabbit aortas by ex vivo gene transferring of dimethylarginine dimethylaminohydrolase-2. Int J Cardiol 2010;144:180186.
  • 9
    Abhary S, Burdon KP, Kuot A, Javadiyan S, Whiting MJ, Kasmeridis N, et al. Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes. PLoS One 2010;5:e9462.
  • 10
    Aggarwal S, Gross CM, Kumar S, Dimitropolou C, Sharma S, Gorshkov BA, et al. Dimethylarginine dimethylaminohydrolase II overexpression attenuates lipopolysaccharide mediated lung leak in acute lung injury. Am J Respir Cell Mol Biol 2014;50:614625.
  • 11
    Hasegawa K, Wakino S, Tatematsu S, Yoshioka K, Homma K, Sugano N, et al. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2. Circ Res 2007;101:e2e10.
  • 12
    Achan V, Tran CT, Arrigoni F, Whitley GS, Leiper JM, Vallance P. All-trans-retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethylarginine dimethylaminohydrolase. Circ Res 2002;90:764769.